First-in-Human Evaluation of Safety, Pharmacokinetics and Muscle Glycogen Lowering of a Novel Glycogen Synthase 1 Inhibitor for the Treatment of Pompe DiseaseCLINICAL PHARMACOLOGY & THERAPEUTICSIF5.52024-10-221OAAI
Small-molecule inhibition of glycogen synthase 1 for the treatment of Pompe disease and other glycogen storage disordersSCIENCE TRANSLATIONAL MEDICINEIF14.62024-01-179PRE
Small molecule inhibition of glycogen synthase 1 restores autophagolysosomal and metabolic pathway dysfunction in a mouse model of Pompe diseaseMOLECULAR GENETICS AND METABOLISMIF3.52023-02-010PRE
Quantification of peripheral blood mononuclear cell (PBMC) glycogen as a novel biomarker for therapeutic intervention in Pompe diseaseMOLECULAR GENETICS AND METABOLISMIF3.52023-02-010PRE
The structural mechanism of human glycogen synthesis by the GYS1-GYG1 complexCELL REPORTSIF6.92022-07-0113OA
Molecular architecture determines brain delivery of a transferrin receptor-targeted lysosomal enzyme分子结构决定了转铁蛋白受体靶向溶酶体酶的脑递送JOURNAL OF EXPERIMENTAL MEDICINEIF10.62022-02-2833OAAI
Pharmacology of small molecule inhibitors of GYS1 in a mouse model of Pompe diseaseMOLECULAR GENETICS AND METABOLISMIF3.52022-02-011PRE
In-vitro characterization of MZE001, an orally active GYS1 inhibitor to treat Pompe diseaseMOLECULAR GENETICS AND METABOLISMIF3.52022-02-012PRE
Genetic reduction of muscle glycogen is well tolerated in UK Biobank participantsMOLECULAR GENETICS AND METABOLISMIF3.52022-02-012PRE
Substrate reduction therapy for Pompe disease: Small molecule inhibition of glycogen synthase 1 in preclinical modelsMOLECULAR GENETICS AND METABOLISMIF3.52022-02-010PRE
Brain delivery and activity of a lysosomal enzyme using a blood-brain barrier transport vehicle in miceSCIENCE TRANSLATIONAL MEDICINEIF14.62020-05-27132PREAI
Novel FACS based method demonstrates CNS cell-type distribution and efficacy of a BBB penetrant ERT in a mouse model of MPS IIMOLECULAR GENETICS AND METABOLISMIF3.52020-02-010PREAI
Brain delivery and efficacy of an intravenously-administered lysosomal enzyme using a blood-brain barrier transport vehicleMOLECULAR GENETICS AND METABOLISMIF3.52020-02-011PREAI
Improved brain uptake and efficacy of iduronate 2-sulfatase with the enzyme transport vehicleMOLECULAR GENETICS AND METABOLISMIF3.52019-02-011PREAI
A mouse model of autism implicates endosome pH in the regulation of presynaptic calcium entryNATURE COMMUNICATIONSIF15.72018-01-2325OAAI
Chemical Induction of Misfolded Prion Protein Conformers in Cell CultureJOURNAL OF BIOLOGICAL CHEMISTRYIF3.92010-04-0122OAAI
Cell division modulates prion accumulation in cultured cellsPROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICAIF9.12007-11-1387OAAI